Skip to content

Analysising the Marginal Bone Loss, Torque and Implant Stability Placed in Bone and Tissue Level Dental Implants

Marginal Bone Loss in Implants Placed in Bone Level and Tissue Level

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07288606
Enrollment
20
Registered
2025-12-17
Start date
2022-12-02
Completion date
2026-12-30
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Implant Stability

Keywords

Bone level, tissue level, osseointegration, biomechanical analysis, implant design, Insertion torque

Brief summary

It is a prospective clinical study to compare two implants of the same brand of a similar design for implantation \[either at the bone tissue level or at the soft tissue level\], in order to evaluate the marginal bone loss of each dental implant in mm. 96 patients will be analyzed (an expected N of 48 per group, hoping to reach 100 implants per arm).

Detailed description

it is a study to evualte the marginal bone loss in bone level and tissue level dental implants

Interventions

PROCEDUREDental implant placement

Surgical placement of Bone-level and Tissue-level dental implants.

Sponsors

University of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Investigator)

Intervention model description

placement of dental implants in bone level and tissue level

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of both sexes, over 18 years of age, who need dental implant placement for prosthetic rehabilitation. Whether partially or completely in both the maxilla and the mandible. * Patients with residual alveolar ridge with at least 8 mm of bone height and 4 mm of width. * Patients must have the ability to understand and decide when voluntarily signing the informed consent before carrying out any intervention related to the study. * Patients who, after being informed about the objectives and procedures of the research, agree will sign the informed consent form. And they are ready to carry out the different study visits.

Exclusion criteria

* Patients with uncontrolled systemic diseases (ASA ≥ III). * Patients who do not have 8mm bone height and/or 4mm width * Patients who require bone regeneration * Patients with severe periodontal disease or acute pericoronitis. * Pregnant and breastfeeding women. * Patients with Deficient or Inadequate Oral Hygiene. * Patients with severe bruxism. * Patients taking bisphosphonates or other antiresority medications. * Smoker of more than 10 cigarettes/day. * Patients with uncontrolled diabetes mellitus. * Psychiatric illnesses or unrealistic expectations. * Immunodepressed or immunocompromised patient.

Design outcomes

Primary

MeasureTime frameDescription
marginal bone loss6 monthsmm
Torqueup to 24 weeksN·cm

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026